Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
1.36
Dollar change
+0.14
Percentage change
11.48
%
IndexRUT P/E- EPS (ttm)-1.40 Insider Own2.55% Shs Outstand31.20M Perf Week-5.56%
Market Cap42.43M Forward P/E- EPS next Y-0.81 Insider Trans0.00% Shs Float30.40M Perf Month-29.53%
Income-40.91M PEG- EPS next Q-0.37 Inst Own29.80% Short Float4.73% Perf Quarter-25.68%
Sales0.08M P/S530.34 EPS this Y22.73% Inst Trans12.48% Short Ratio5.09 Perf Half Y-82.91%
Book/sh1.22 P/B1.11 EPS next Y42.57% ROA-47.84% Short Interest1.44M Perf Year-74.14%
Cash/sh2.52 P/C0.54 EPS next 5Y- ROE-100.05% 52W Range1.19 - 10.24 Perf YTD-73.23%
Dividend Est.- P/FCF- EPS past 5Y22.80% ROI-103.95% 52W High-86.72% Beta0.10
Dividend TTM- Quick Ratio10.25 Sales past 5Y-22.00% Gross Margin-895.06% 52W Low14.29% ATR (14)0.11
Dividend Ex-Date- Current Ratio10.25 EPS Y/Y TTM26.97% Oper. Margin-55504.94% RSI (14)40.02 Volatility7.87% 7.70%
Employees49 Debt/Eq0.04 Sales Y/Y TTM80.00% Profit Margin-50512.35% Recom1.40 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q24.11% Payout- Rel Volume1.86 Prev Close1.22
Sales Surprise- EPS Surprise3.90% Sales Q/Q- EarningsNov 18 BMO Avg Volume282.71K Price1.36
SMA20-9.15% SMA50-18.23% SMA200-73.99% Trades Volume526,492 Change11.48%
Date Action Analyst Rating Change Price Target Change
Aug-07-24Downgrade B. Riley Securities Buy → Neutral $16 → $2
May-14-24Initiated Stephens Overweight $25
Sep-06-23Initiated HSBC Securities Buy $11.60
Feb-21-23Downgrade William Blair Outperform → Mkt Perform
Sep-08-22Initiated Cantor Fitzgerald Overweight $20
Aug-25-22Initiated B. Riley Securities Buy $16
Nov-05-20Initiated Alliance Global Partners Buy $25
Dec-06-17Initiated B. Riley FBR, Inc. Buy $2.75
Oct-23-17Resumed ROTH Capital Buy $6
Sep-14-17Initiated Maxim Group Buy $3
Nov-18-24 08:00AM
Nov-14-24 07:02PM
Nov-04-24 07:30AM
Oct-18-24 12:00PM
Sep-23-24 04:52AM
08:00AM Loading…
Sep-20-24 08:00AM
Sep-12-24 07:59AM
Aug-21-24 05:00AM
Aug-05-24 06:59PM
07:00AM
Aug-01-24 08:00AM
Jul-25-24 08:45AM
07:30AM
Jul-11-24 02:23PM
Jul-02-24 05:05PM
09:40AM Loading…
Jun-20-24 09:40AM
Jun-18-24 08:45AM
Jun-17-24 08:45AM
08:00AM
Jun-14-24 08:30AM
Jun-11-24 08:30AM
Jun-10-24 07:22PM
08:30AM
Jun-07-24 07:30AM
May-15-24 08:30AM
May-14-24 06:38PM
10:24AM
07:46AM
May-13-24 08:30AM
May-07-24 08:00AM
08:00AM Loading…
Apr-18-24 08:00AM
Apr-15-24 12:54PM
Apr-01-24 08:00AM
Mar-26-24 07:18AM
Mar-15-24 06:15AM
Mar-11-24 07:30AM
Feb-26-24 07:30AM
Feb-25-24 01:37PM
Feb-23-24 07:30AM
Jan-02-24 07:30AM
Dec-11-23 08:15AM
07:45AM
Dec-08-23 08:00AM
Nov-06-23 07:30AM
Nov-02-23 04:15PM
09:05AM
Oct-31-23 08:15AM
Oct-04-23 07:30AM
Sep-27-23 09:05AM
Sep-07-23 08:40AM
Aug-31-23 07:00AM
Aug-21-23 07:00AM
Aug-15-23 09:41AM
Jul-24-23 07:00AM
Jun-26-23 07:00AM
Jun-23-23 08:00AM
Jun-16-23 07:00AM
Jun-14-23 07:00AM
Jun-12-23 07:00AM
Jun-07-23 07:00AM
May-22-23 07:00AM
May-17-23 06:34AM
May-11-23 11:18AM
May-10-23 07:00AM
Apr-28-23 08:00AM
Apr-27-23 10:36AM
Apr-19-23 08:45AM
08:30AM
Apr-03-23 07:00AM
Mar-16-23 08:45AM
Mar-15-23 08:00AM
Feb-27-23 08:00AM
Feb-24-23 04:04PM
Feb-18-23 04:30PM
Feb-14-23 07:30AM
Feb-06-23 07:30AM
Jan-17-23 07:30AM
Jan-12-23 08:00AM
Dec-12-22 08:00AM
Dec-08-22 07:30AM
Nov-10-22 08:15AM
Nov-03-22 09:20AM
Nov-02-22 08:17AM
Oct-31-22 12:12PM
12:00PM
06:00AM
Oct-27-22 07:30AM
Oct-26-22 09:17AM
07:30AM
Oct-25-22 07:30AM
Sep-26-22 07:30AM
Sep-21-22 07:30AM
Sep-08-22 01:50PM
07:00AM
Aug-15-22 10:15AM
Aug-11-22 08:55AM
Aug-09-22 06:25PM
Aug-04-22 07:35AM
May-19-22 09:40AM
Apr-25-22 07:30AM
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.